NOP14

NOP14 is an evolutionarily conserved nucleolar ribosome biogenesis factor required for production of the small (40S) ribosomal subunit, with depletion selectively impairing processing of 20S pre-rRNA to mature 18S rRNA (PMID:11694595). It executes this function through a direct physical interaction with EMG1, which it retains in the nucleus; loss of this NOP14–EMG1 association blocks 18S rRNA maturation and 40S subunit assembly (PMID:11694595, PMID:35117729). Beyond its core role in ribosome assembly, NOP14 couples ribosome biogenesis to growth signaling: acting downstream of the mTORC1–S6K axis, it is required for recruitment of mTORC2 to ER-bound ribosomes, supporting mTORC2 activation and Akt stabilization (PMID:38272224). NOP14 also governs importin-dependent nuclear translocation of NF-κB p65, controlling inflammatory gene expression in endothelial cells (PMID:34607110), and stabilizes mutant p53 mRNA to suppress p21 via miR-17-5p induction in pancreatic cancer (PMID:28280038). Across multiple cancer and vascular contexts NOP14 modulates Wnt/β-catenin signaling through NRIP1 and GSK-3β, though the direction of this effect is context-dependent (PMID:35117729).

1. 2001 High

   Established NOP14's core cellular function by showing it is a nucleolar factor essential for the small ribosomal subunit, answering what process the protein serves.

   Evidence Yeast depletion with Northern analysis of pre-rRNA processing intermediates and 40S subunit levels

   PMID:11694595

   Open questions at the time

   • Does not define the molecular activity of NOP14 within the processing machinery
   • Structural basis for pre-rRNA processing role not resolved
2. 2001 High

   Identified EMG1 as a direct NOP14 partner whose nuclear localization depends on NOP14, linking the interaction mechanistically to 18S maturation.

   Evidence Co-immunoprecipitation, subcellular fractionation, and genetic depletion in yeast

   PMID:11694595

   Open questions at the time

   • Interaction interface not mapped
   • Whether other 40S assembly factors are recruited by NOP14 unknown
3. 2015 Low

   First placed NOP14 in a cancer signaling context, linking it to ERα and Wnt/β-catenin via NRIP1 upregulation.

   Evidence Overexpression/knockdown with Western blot and tumor assays in breast cancer cells

   PMID:26213846

   Open questions at the time

   • No direct mechanistic assay connecting NOP14 to NRIP1 regulation
   • Single lab, protein-level readouts only
4. 2017 Medium

   Revealed a non-ribosomal RNA-stability function, showing NOP14 stabilizes mutant p53 mRNA to drive a p21-suppressing miR-17-5p axis.

   Evidence Knockdown/overexpression, mRNA stability assays, and in vivo pancreatic cancer models

   PMID:28280038

   Open questions at the time

   • Direct RNA-binding by NOP14 not demonstrated
   • Not independently replicated
   • Mechanism of mRNA stabilization unknown
5. 2020 Medium

   Confirmed the NOP14–EMG1 interaction biochemically in human cells and tied co-expression to suppression of Wnt/β-catenin signaling components.

   Evidence GST pulldown, co-immunoprecipitation, and overexpression in melanoma cells

   PMID:35117729

   Open questions at the time

   • Functional link to Wnt is correlative protein-level
   • Whether ribosome biogenesis role mediates the Wnt effect untested
6. 2021 Medium

   Defined NOP14 as a controller of importin-dependent NF-κB p65 nuclear translocation and the target of the anti-inflammatory compound vioprolide A.

   Evidence siRNA knockdown, pharmacological inhibition, NF-κB reporter and translocation imaging, and in vivo models

   PMID:34607110

   Open questions at the time

   • Direct binding of NOP14 to importins or p65 not shown
   • How a ribosome biogenesis factor controls nuclear import unclear
7. 2021 Low

   Extended the NRIP1/GSK-3β/β-catenin axis to colorectal cancer, linking NOP14 to GSK-3β phosphorylation-inactivation.

   Evidence Overexpression/knockdown, Western blot, migration and viability assays

   PMID:34218653

   Open questions at the time

   • No biochemical reconstitution of the pathway
   • Direction of Wnt effect differs from other contexts
8. 2022 Low

   Used pharmacological epistasis to place NOP14 upstream of Wnt/β-catenin in melanoma stem-like cells, affecting stemness.

   Evidence Lentiviral overexpression with BML-284 Wnt-activator rescue in A375/A875 cells

   PMID:35282769

   Open questions at the time

   • No direct biochemical mechanism linking NOP14 to Wnt components
   • Single lab epistasis only
9. 2024 Medium

   Connected NOP14's ribosome role to growth signaling, showing it acts downstream of mTORC1-S6K to recruit mTORC2 to ER-bound ribosomes and stabilize Akt.

   Evidence Knockdown/overexpression, subcellular fractionation, Co-IP, and phospho-Akt Western blot in cancer cell lines

   PMID:38272224

   Open questions at the time

   • Direct NOP14–mTORC2 contacts not mapped
   • Whether effect requires intact 40S biogenesis untested
10. 2026 Low

    Showed NOP14 activates Wnt/β-catenin and ribosome biogenesis to drive endothelial proliferation and angiogenesis in diabetic retinopathy.

    Evidence Knockdown/overexpression, Wnt reporter, in vivo PDR model and HG-treated HRECs

    PMID:41638389

    Open questions at the time

    • Wnt link inferred from protein levels without reconstitution
    • Opposite Wnt directionality versus melanoma context unexplained

• How a single nucleolar 40S biogenesis factor mechanistically controls disparate signaling outputs (NF-κB import, mTORC2 recruitment, mRNA stability, Wnt direction) remains unresolved.
• No unifying biochemical mechanism distinguishing ribosome-dependent from ribosome-independent functions
• Context-dependent direction of Wnt regulation unexplained
• No structural model of NOP14 or its interaction interfaces